Quantitative Sensory Testing Across Chronic Pain Conditions and Use in Special Populations.
Author
Weaver, Kristen RGriffioen, Mari A
Klinedinst, N Jennifer
Galik, Elizabeth
Duarte, Ana C
Colloca, Luana
Resnick, Barbara
Dorsey, Susan G
Renn, Cynthia L
Date
2022-01-28Journal
Frontiers in Pain Research (Lausanne, Switzerland)Publisher
Frontiers Media S.A.Type
Article
Metadata
Show full item recordAbstract
Chronic pain imposes a significant burden to the healthcare system and adversely affects patients' quality of life. Traditional subjective assessments, however, do not adequately capture the complex phenomenon of pain, which is influenced by a multitude of factors including environmental, developmental, genetic, and psychological. Quantitative sensory testing (QST), established as a protocol to examine thermal and mechanical sensory function, offers insight on potential mechanisms contributing to an individual's experience of pain, by assessing their perceived response to standardized delivery of stimuli. Although the use of QST as a research methodology has been described in the literature in reference to specific pain populations, this manuscript details application of QST across a variety of chronic pain conditions. Specific conditions include lower extremity chronic pain, knee osteoarthritis, chronic low back pain, temporomandibular joint disorder, and irritable bowel syndrome. Furthermore, we describe the use of QST in placebo/nocebo research, and discuss the use of QST in vulnerable populations such as those with dementia. We illustrate how the evaluation of peripheral sensory nerve function holds clinical promise in targeting interventions, and how using QST can enhance patient education regarding prognostic outcomes with particular treatments. Incorporation of QST methodology in research investigations may facilitate the identification of common mechanisms underlying chronic pain conditions, guide the development of non-pharmacological behavioral interventions to reduce pain and pain-related morbidity, and enhance our efforts toward reducing the burden of chronic pain.Rights/Terms
Copyright © 2022 Weaver, Griffioen, Klinedinst, Galik, Duarte, Colloca, Resnick, Dorsey and Renn.Keyword
dementiairritable bowel syndrome (IBS)
low back pain
osteoarthritis
placebo
temporomandibular joint disorder (TMD)
Identifier to cite or link to this item
http://hdl.handle.net/10713/18329ae974a485f413a2113503eed53cd6c53
10.3389/fpain.2021.779068
Scopus Count
Collections
Related articles
- Association between quantitative sensory testing and pain or disability in paediatric chronic pain: protocol for a systematic review and meta-analysis.
- Authors: Schoth DE, Blankenburg M, Wager J, Broadbent P, Zhang J, Zernikow B, Liossi C
- Issue date: 2019 Oct 7
- Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus.
- Authors: Backonja MM, Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, Edwards RR, Freeman R, Gracely R, Haanpaa MH, Hansson P, Hatem SM, Krumova EK, Jensen TS, Maier C, Mick G, Rice AS, Rolke R, Treede RD, Serra J, Toelle T, Tugnoli V, Walk D, Walalce MS, Ware M, Yarnitsky D, Ziegler D
- Issue date: 2013 Sep
- Quantitative sensory testing (QST). English version.
- Authors: Mücke M, Cuhls H, Radbruch L, Baron R, Maier C, Tölle T, Treede RD, Rolke R
- Issue date: 2021 Nov
- Do chronic low back pain subgroups derived from dynamic quantitative sensory testing exhibit differing multidimensional profiles?
- Authors: Rabey M, Kendell M, Koren S, Silva I, Watts L, Wong C, Slater H, Smith A, Beales D
- Issue date: 2021 Jul 27
- Neuropathic pain: is quantitative sensory testing helpful?
- Authors: Krumova EK, Geber C, Westermann A, Maier C
- Issue date: 2012 Aug